@Canageek @AmazonChique 1/ Also, the fact that the cost is to the govt doesn’t invalidate that there’s a cost. This UK study, for example, only goes as far as to recommend targeted screening for selected group once a year: https://t.co/G7TpuLjPF2 I don’t s
RT @HeoroCom: #Model: annual #HIV screening of higher risk groups could be #costeffective in UK, from £17,500/QALY gain https://t.co/R9ewXW…
#Model: annual #HIV screening of higher risk groups could be #costeffective in UK, from £17,500/QALY gain https://t.co/R9ewXWzbak
Expanded HIV Testing in Low-Prev, High-Income Areas - UK Cost-Effectiveness http://t.co/hQtWO90Zn0 HT @uclaanderson http://t.co/rRY5jIggqA
Expanded HIV Testing in Low-Prev, High-Income Areas - UK Cost-Effectiveness http://t.co/hQtWO90Zn0 HT @uclaanderson http://t.co/rRY5jIggqA
Expanded HIV Testing in Low-Prevalence, High-Income Countries: A Cost-Effectiveness Analysis for the UK. http://t.co/ddYSHfpV1Q
Expanded HIV Testing in Low-Prev, High-Income Areas - UK Cost-Effectiveness http://t.co/nPUUu8BrmG HT @uclaanderson http://t.co/rRY5jIggqA
Expanded HIV Testing in Low-Prev, High-Income Areas - UK Cost-Effectiveness http://t.co/nPUUu8BrmG HT @uclaanderson http://t.co/rRY5jIggqA